Amirhossein Yadegar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Amirhossein Yadegar has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Manouchehr Nakhjavani
Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
8 shared publications Alireza Esteghamati
Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
5 shared publicationsFatemeh Mohammadi
Endocrinology and Metabolism Research Center (EMRC) Vali‐Asr Hospital, Tehran University of Medical Sciences Tehran Iran
5 shared publications- Soghra Rabizadeh
Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
5 shared publications - Alireza Esteghamati
Endocrinology and Metabolism Research Center (EMRC) Vali‐Asr Hospital, Tehran University of Medical Sciences Tehran Iran
4 shared publications Soghra Rabizadeh
Affiliation Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in Scientific Reports
Nonlinear associations and diagnostic performance of surrogate insulin resistance indices for diabetic retinopathy in type 2 diabetes
- 3 November 2026
- Published by Springer Nature in Scientific Reports
Open AccessNonlinear associations and diagnostic performance of surrogate insulin resistance indices for diabetic retinopathy in type 2 diabetes
- Open Access
- 25 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
Reconceptualizing Dyslipidemia: Diversity of Lipid Imbalances and Their Clinical Implications; A Narrative Review
Background and Aims: The traditional definition of dyslipidemia focuses on isolated lipid changes (LDL‐C, HDL‐C, triglycerides) and may not fully capture the biological complexity or clinical variability of lipid imbalances. Recent evidence challenges this narrow view, suggesting that dyslipidemia involves broader disruptions in lipid homeostasis influenced not only by metabolic disorders but also by pharmacological treatments. This review aims to reconceptualize dyslipidemia as a multidimensional disorder, emphasizing lipid ratios, subfractions (e.g., oxidized LDL‐C, small dense LDL‐C), and integrated lipid patterns rather than single‐parameter deviations. Methods: A narrative review was conducted focusing on patterns of dyslipidemia, lipid ratios, lipoprotein subfractions, and emerging cardiometabolic biomarkers. Relevant studies were identified through PubMed, Google Scholar, Scopus, and Web of Science up to April 2026 using predefined keywords including “dyslipidemia,” “lipid ratio,” “small dense LDL,” “oxidized LDL,” “TyG index,” “AIP,” and related terms. Articles were screened for clinical relevance and selected through author consensus. As a narrative review, no statistical tests were applied. Results: Mixed dyslipidemia, lipid ratios, and subfractions have been suggested to be associated with clinically relevant risks even when traditional lipid values appear normal. Observational evidence suggests that these markers may offer additive or higher predictive value for cardiovascular disease, metabolic dysfunction, renal outcomes, and cancer than isolated lipid measurements. Although supportive evidence exists, current guidelines have not fully adopted lipid ratios or novel markers in clinical guidelines. Conclusion: Understanding dyslipidemia as a complex imbalance of lipid metabolism highlights the importance of lipid interactions, functional quality, and systemic balance. This reconceptualization may enhance patient risk stratification and guide diagnostic and therapeutic strategies beyond conventional numerical targets.
- 25 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
Open AccessReconceptualizing Dyslipidemia: Diversity of Lipid Imbalances and Their Clinical Implications; A Narrative Review
Background and Aims: The traditional definition of dyslipidemia focuses on isolated lipid changes (LDL‐C, HDL‐C, triglycerides) and may not fully capture the biological complexity or clinical variability of lipid imbalances. Recent evidence challenges this narrow view, suggesting that dyslipidemia involves broader disruptions in lipid homeostasis influenced not only by metabolic disorders but also by pharmacological treatments. This review aims to reconceptualize dyslipidemia as a multidimensional disorder, emphasizing lipid ratios, subfractions (e.g., oxidized LDL‐C, small dense LDL‐C), and integrated lipid patterns rather than single‐parameter deviations. Methods: A narrative review was conducted focusing on patterns of dyslipidemia, lipid ratios, lipoprotein subfractions, and emerging cardiometabolic biomarkers. Relevant studies were identified through PubMed, Google Scholar, Scopus, and Web of Science up to April 2026 using predefined keywords including “dyslipidemia,” “lipid ratio,” “small dense LDL,” “oxidized LDL,” “TyG index,” “AIP,” and related terms. Articles were screened for clinical relevance and selected through author consensus. As a narrative review, no statistical tests were applied. Results: Mixed dyslipidemia, lipid ratios, and subfractions have been suggested to be associated with clinically relevant risks even when traditional lipid values appear normal. Observational evidence suggests that these markers may offer additive or higher predictive value for cardiovascular disease, metabolic dysfunction, renal outcomes, and cancer than isolated lipid measurements. Although supportive evidence exists, current guidelines have not fully adopted lipid ratios or novel markers in clinical guidelines. Conclusion: Understanding dyslipidemia as a complex imbalance of lipid metabolism highlights the importance of lipid interactions, functional quality, and systemic balance. This reconceptualization may enhance patient risk stratification and guide diagnostic and therapeutic strategies beyond conventional numerical targets.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Diabetes Research
- Vol. 2026 (1) , 6993567
Association of Nontraditional Lipid Indices With Poor Glycemic Control in Patients With Type 2 Diabetes: A Cross‐Sectional Study
Background: This study investigated the association between poor glycemic control, defined as HbA1c ≥ 7.5%, and multiple nontraditional lipid indices, including AC, AIP, LCI, TG/HDL‐C ratio, CRI‐I, and CRI‐II, and to evaluate their diagnostic performance for identifying poor glycemic control. Methods: In this cross‐sectional study, 6424 individuals diagnosed with Type 2 diabetes (T2D) who visited a diabetes clinic from 2014 to 2024 were included. The relationships between nontraditional lipid indices and poor glycemic control were evaluated using RCS models and multivariable logistic regression. Diagnostic performance was examined using ROC analysis. Results: Nontraditional lipid indices were significantly elevated in patients with poor glycemic control ( p < 0.001). In RCS models, significant nonlinear associations were observed between all lipid indices and poor glycemic control, with progressively higher odds of HbA1c ≥ 7.5% as index values increased ( p for nonlinearity < 0.05). When analyzed as continuous variables, all indices were positively associated with poor glycemic control, with AIP showing the strongest association (OR = 2.25 [1.84–2.76]). Individuals in higher quartiles of each lipid index had significantly greater odds of poor glycemic control compared with those in the first quartile. All indices showed modest discriminatory ability (AUCs ≥ 0.684) for poor glycemic control, with AIP demonstrating the highest AUC (0.687 [0.657–0.718]). However, no statistically significant differences in AUC were detected among the indices. Conclusions: The observed nonlinear associations between nontraditional lipid indices and poor glycemic control highlight the close interplay between atherogenic dyslipidemia and glycemic dysregulation. As these indices are derived from routinely measured lipid parameters, they can act as practical complementary tools for identifying individuals at higher risk of poor glycemic control, especially in settings where HbA1c measurement is limited or not cost‐effective. Further research is required to confirm these findings and determine causal relationships.
- 1 January 2026
- Published by Wiley in Journal of Diabetes Research
- Vol. 2026 (1) , 6993567
Open AccessAssociation of Nontraditional Lipid Indices With Poor Glycemic Control in Patients With Type 2 Diabetes: A Cross‐Sectional Study
Background: This study investigated the association between poor glycemic control, defined as HbA1c ≥ 7.5%, and multiple nontraditional lipid indices, including AC, AIP, LCI, TG/HDL‐C ratio, CRI‐I, and CRI‐II, and to evaluate their diagnostic performance for identifying poor glycemic control. Methods: In this cross‐sectional study, 6424 individuals diagnosed with Type 2 diabetes (T2D) who visited a diabetes clinic from 2014 to 2024 were included. The relationships between nontraditional lipid indices and poor glycemic control were evaluated using RCS models and multivariable logistic regression. Diagnostic performance was examined using ROC analysis. Results: Nontraditional lipid indices were significantly elevated in patients with poor glycemic control ( p < 0.001). In RCS models, significant nonlinear associations were observed between all lipid indices and poor glycemic control, with progressively higher odds of HbA1c ≥ 7.5% as index values increased ( p for nonlinearity < 0.05). When analyzed as continuous variables, all indices were positively associated with poor glycemic control, with AIP showing the strongest association (OR = 2.25 [1.84–2.76]). Individuals in higher quartiles of each lipid index had significantly greater odds of poor glycemic control compared with those in the first quartile. All indices showed modest discriminatory ability (AUCs ≥ 0.684) for poor glycemic control, with AIP demonstrating the highest AUC (0.687 [0.657–0.718]). However, no statistically significant differences in AUC were detected among the indices. Conclusions: The observed nonlinear associations between nontraditional lipid indices and poor glycemic control highlight the close interplay between atherogenic dyslipidemia and glycemic dysregulation. As these indices are derived from routinely measured lipid parameters, they can act as practical complementary tools for identifying individuals at higher risk of poor glycemic control, especially in settings where HbA1c measurement is limited or not cost‐effective. Further research is required to confirm these findings and determine causal relationships.
- Open Access
- 7 October 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (10) , e0331756
Can lipid indices aid in predicting diabetic kidney disease? Findings from a cross-sectional, matched case-control study
Background: This study explored the association between lipid indices, including AC, TG/HDL-C ratio, AIP, and LCI, and diabetic kidney disease (DKD). Methods: A cross-sectional, matched case-control study was conducted involving patients with type 2 diabetes (T2D), divided into two groups based on the presence of DKD. The groups were matched for age and duration of diabetes. The association between lipid indices and DKD was assessed using RCS, multivariable logistic regression, and ROC curve analysis. Results: The study included 2940 individuals with T2D, with 1470 in each group. A nonlinear association was observed between all lipid indices and the presence of DKD. These lipid indices demonstrated relatively high predictive ability for DKD, with all AUC values higher than 0.707. The AIP and TG/HDL-C ratio had the highest AUCs of 0.717 and 0.713, respectively. Both indices also exhibited the highest sensitivity at 68%, while LCI showed the highest specificity at 79%. After adjusting for potential confounders, all lipid indices were significantly associated with DKD in the multivariable logistic regression analysis. Non-linear associations were found between lipid indices and components of DKD. All lipid indices demonstrated significant relationships with uACR ≥ 30 mg/g, whereas only AIP showed a significant association with eGFR < 60 mL/min/1.73m2. According to the ROC curve analysis, AIP was the most effective at identifying reduced eGFR (AUC = 0.676 [0.637–0.712]), and LCI was the best performer for detecting elevated uACR (AUC = 0.741 [0.701–0.783]). Conclusions: Lipid indices may serve as valuable, non-invasive tools for the early detection of DKD, potentially leading to effective diabetes management and reducing the burden of DKD.
- 7 October 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (10) , e0331756
Open AccessCan lipid indices aid in predicting diabetic kidney disease? Findings from a cross-sectional, matched case-control study
Background: This study explored the association between lipid indices, including AC, TG/HDL-C ratio, AIP, and LCI, and diabetic kidney disease (DKD). Methods: A cross-sectional, matched case-control study was conducted involving patients with type 2 diabetes (T2D), divided into two groups based on the presence of DKD. The groups were matched for age and duration of diabetes. The association between lipid indices and DKD was assessed using RCS, multivariable logistic regression, and ROC curve analysis. Results: The study included 2940 individuals with T2D, with 1470 in each group. A nonlinear association was observed between all lipid indices and the presence of DKD. These lipid indices demonstrated relatively high predictive ability for DKD, with all AUC values higher than 0.707. The AIP and TG/HDL-C ratio had the highest AUCs of 0.717 and 0.713, respectively. Both indices also exhibited the highest sensitivity at 68%, while LCI showed the highest specificity at 79%. After adjusting for potential confounders, all lipid indices were significantly associated with DKD in the multivariable logistic regression analysis. Non-linear associations were found between lipid indices and components of DKD. All lipid indices demonstrated significant relationships with uACR ≥ 30 mg/g, whereas only AIP showed a significant association with eGFR < 60 mL/min/1.73m2. According to the ROC curve analysis, AIP was the most effective at identifying reduced eGFR (AUC = 0.676 [0.637–0.712]), and LCI was the best performer for detecting elevated uACR (AUC = 0.741 [0.701–0.783]). Conclusions: Lipid indices may serve as valuable, non-invasive tools for the early detection of DKD, potentially leading to effective diabetes management and reducing the burden of DKD.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma Are Correlates of Uncontrolled Hypertension in Patients With Type 2 Diabetes
Aims: Hypertension (HTN) may be associated with increased oxidative stress, potentially contributing to vascular damage and metabolic dysfunction in Type 2 diabetes (T2D). This study aims to investigate this possible link to better understand its crucial role in improving clinical outcomes in patients with T2D. Methods: In this cross‐sectional study, 235 patients with T2D were recruited. Clinical and demographic characteristics of the individuals were collected. Participants were divided into three groups based on their HTN status, including normotensive ( n = 145), controlled hypertensive ( n = 54), and uncontrolled hypertensive ( n = 36). Advanced glycation end products (AGEs), advanced oxidation protein products (AOPPs), and ferric reducing ability of plasma (FRAP) levels were measured using quantitative methods. Finally, the association between these oxidation‐related indices and HTN status was evaluated. Analysis of variances, chi‐square test, and receiver operating characteristic curve analyses were conducted to evaluate the associations between these indices and HTN among individuals diagnosed with T2D. Results: Serum levels of AGEs were significantly higher in the HTN population compared to the normotensive population ( p v a l u e < 0.05). Similarly, AGE levels were increased in the uncontrolled HTN population compared to the controlled HTN population, a pattern also observed for AOPP ( p v a l u e < 0.05). Conversely, serum FRAP levels were significantly lower in the HTN population compared to the normotensive population ( p v a l u e < 0.05), as well as in the uncontrolled HTN population compared to the controlled HTN population ( p v a l u e < 0.05). Among these markers, AGEs showed the highest odds ratio for uncontrolled HTN, with an unadjusted odds ratio of 1.062 (1.022–1.103) and an adjusted odds ratio of 1.067 (1.022–1.113) ( p v a l u e < 0.05). AGEs, AOPP, and FRAP performed well in detecting uncontrolled HTN with area under the curve of 0.758 (0.680–0.837), 0.722 (0.637–0.807), and 0.764 (0.664–0.828), respectively ( p v a l u e < 0.001). Conclusion: Oxidative stress indices are associated with HTN status and correlated with uncontrolled HTN in populations with T2D.
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Open AccessAdvanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma Are Correlates of Uncontrolled Hypertension in Patients With Type 2 Diabetes
Aims: Hypertension (HTN) may be associated with increased oxidative stress, potentially contributing to vascular damage and metabolic dysfunction in Type 2 diabetes (T2D). This study aims to investigate this possible link to better understand its crucial role in improving clinical outcomes in patients with T2D. Methods: In this cross‐sectional study, 235 patients with T2D were recruited. Clinical and demographic characteristics of the individuals were collected. Participants were divided into three groups based on their HTN status, including normotensive ( n = 145), controlled hypertensive ( n = 54), and uncontrolled hypertensive ( n = 36). Advanced glycation end products (AGEs), advanced oxidation protein products (AOPPs), and ferric reducing ability of plasma (FRAP) levels were measured using quantitative methods. Finally, the association between these oxidation‐related indices and HTN status was evaluated. Analysis of variances, chi‐square test, and receiver operating characteristic curve analyses were conducted to evaluate the associations between these indices and HTN among individuals diagnosed with T2D. Results: Serum levels of AGEs were significantly higher in the HTN population compared to the normotensive population ( p v a l u e < 0.05). Similarly, AGE levels were increased in the uncontrolled HTN population compared to the controlled HTN population, a pattern also observed for AOPP ( p v a l u e < 0.05). Conversely, serum FRAP levels were significantly lower in the HTN population compared to the normotensive population ( p v a l u e < 0.05), as well as in the uncontrolled HTN population compared to the controlled HTN population ( p v a l u e < 0.05). Among these markers, AGEs showed the highest odds ratio for uncontrolled HTN, with an unadjusted odds ratio of 1.062 (1.022–1.103) and an adjusted odds ratio of 1.067 (1.022–1.113) ( p v a l u e < 0.05). AGEs, AOPP, and FRAP performed well in detecting uncontrolled HTN with area under the curve of 0.758 (0.680–0.837), 0.722 (0.637–0.807), and 0.764 (0.664–0.828), respectively ( p v a l u e < 0.001). Conclusion: Oxidative stress indices are associated with HTN status and correlated with uncontrolled HTN in populations with T2D.
- Open Access
- 5 November 2024
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 7 (6) , e70007
Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study
Background: This study aimed to evaluate the relationships of conventional and calculated lipid indices with obesity or overweight in patients with type 2 diabetes (T2D).Methods: In this cross‐sectional study, all participants were categorised into three groups: normal weight (18 ≤ BMI < 25), overweight (25 ≤ BMI < 30) and obese (BMI ≥ 30). Conventional lipid indices, including triglyceride (TG), total cholesterol, LDL‐C and HDL‐C, were measured. Lipid indices, including the atherogenic index of plasma (AIP), non‐HDL‐C, TC/HDL‐C, LDL‐C/HDL‐C, non‐HLD‐C/HDL‐C (atherogenic index, AI) and lipoprotein combine index (LCI), were calculated. The associations of these lipid indices with obesity and overweight status were evaluated using univariate and multivariate multinomial logistic regression analyses.Results: In this study, 2661 patients with T2D, including 651 patients with normal weight, 1144 with overweight, and 866 with obesity, were recruited. According to a multinomial logistic regression analysis after adjustment for multiple confounders, the odds ratio (OR) was greater for the AIP than for other conventional and calculated lipid indices in overweight and obese patients with T2D. The AIP had a significant relationship with overweight, with an OR of 4.79 (95% CI: 1.65–13.85), and it had a significant relationship with obesity, with an OR of 13.64 (95% CI: 3.96–47.04). According to the ROC curve, with a cut‐off value of 0.68, AIP could predict obesity with 82% sensitivity and 55% specificity (AUC = 0.770, 95% CI: 0.729–0.812, p < 0.001).Conclusion: Compared with other conventional and calculated lipid markers, the AIP is most strongly associated with obesity and overweight in patients with T2D.
- 5 November 2024
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 7 (6) , e70007
Open AccessAtherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study
Background: This study aimed to evaluate the relationships of conventional and calculated lipid indices with obesity or overweight in patients with type 2 diabetes (T2D).Methods: In this cross‐sectional study, all participants were categorised into three groups: normal weight (18 ≤ BMI < 25), overweight (25 ≤ BMI < 30) and obese (BMI ≥ 30). Conventional lipid indices, including triglyceride (TG), total cholesterol, LDL‐C and HDL‐C, were measured. Lipid indices, including the atherogenic index of plasma (AIP), non‐HDL‐C, TC/HDL‐C, LDL‐C/HDL‐C, non‐HLD‐C/HDL‐C (atherogenic index, AI) and lipoprotein combine index (LCI), were calculated. The associations of these lipid indices with obesity and overweight status were evaluated using univariate and multivariate multinomial logistic regression analyses.Results: In this study, 2661 patients with T2D, including 651 patients with normal weight, 1144 with overweight, and 866 with obesity, were recruited. According to a multinomial logistic regression analysis after adjustment for multiple confounders, the odds ratio (OR) was greater for the AIP than for other conventional and calculated lipid indices in overweight and obese patients with T2D. The AIP had a significant relationship with overweight, with an OR of 4.79 (95% CI: 1.65–13.85), and it had a significant relationship with obesity, with an OR of 13.64 (95% CI: 3.96–47.04). According to the ROC curve, with a cut‐off value of 0.68, AIP could predict obesity with 82% sensitivity and 55% specificity (AUC = 0.770, 95% CI: 0.729–0.812, p < 0.001).Conclusion: Compared with other conventional and calculated lipid markers, the AIP is most strongly associated with obesity and overweight in patients with T2D.
- 31 October 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (4) , 423-433
The trend of atherogenic indices in patients with type 2 diabetes after bariatric surgery: a national cohort study
- 31 October 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (4) , 423-433
The trend of atherogenic indices in patients with type 2 diabetes after bariatric surgery: a national cohort study
- Open Access
- 8 May 2024
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 7 (3) , e488
Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross‐Sectional Study
Introduction: This study aimed to assess and compare the prevalence of diabetes complications between men and women with Type 2 diabetes (T2D), as well as how gender relates to these complications.Methods: In this cross‐sectional study, complications of diabetes, including coronary artery disease (CAD), retinopathy, neuropathy and diabetic kidney disease (DKD), were evaluated in 1867 participants with T2D. Additionally, baseline characteristics of the individuals, including anthropometric measurements, metabolic parameters and the use of dyslipidaemia drugs and antihyperglycaemic agents, were assessed. Gender differences in complications were examined using the chi‐squared test. Multivariate logistic regression was employed to investigate the relationship between gender and T2D complications, with and without adjusting for the characteristics of the studied population.Results: In the studied population, 62.1% had at least one complication, and complications were 33.5% for DKD, 29.6% for CAD, 22.9% for neuropathy and 19.1% for retinopathy. The prevalence of CAD and neuropathy was higher in men. However, DKD and retinopathy were more prevalent among women. Odds ratios of experiencing any complication, CAD and retinopathy in men compared with women were 1.57 (95% CI: 1.27–2.03), 2.27 (95% CI: 1.72–2.99) and 0.72 (95% CI: 0.52–0.98), respectively, after adjusting for demographic factors, anthropometric measures, metabolic parameters and the consumption of dyslipidaemia drugs and antihyperglycaemic agents.Conclusion: The prevalence of diabetes complications was significantly higher in men with diabetes, highlighting the need for better treatment adherence. CAD was associated with the male gender, whereas retinopathy was associated with the female gender. Men and women with diabetes should be monitored closely for CAD and retinopathy, respectively, regardless of their age, diabetes duration, anthropometric measures, laboratory findings and medications.
- 8 May 2024
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 7 (3) , e488
Open AccessImpact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross‐Sectional Study
Introduction: This study aimed to assess and compare the prevalence of diabetes complications between men and women with Type 2 diabetes (T2D), as well as how gender relates to these complications.Methods: In this cross‐sectional study, complications of diabetes, including coronary artery disease (CAD), retinopathy, neuropathy and diabetic kidney disease (DKD), were evaluated in 1867 participants with T2D. Additionally, baseline characteristics of the individuals, including anthropometric measurements, metabolic parameters and the use of dyslipidaemia drugs and antihyperglycaemic agents, were assessed. Gender differences in complications were examined using the chi‐squared test. Multivariate logistic regression was employed to investigate the relationship between gender and T2D complications, with and without adjusting for the characteristics of the studied population.Results: In the studied population, 62.1% had at least one complication, and complications were 33.5% for DKD, 29.6% for CAD, 22.9% for neuropathy and 19.1% for retinopathy. The prevalence of CAD and neuropathy was higher in men. However, DKD and retinopathy were more prevalent among women. Odds ratios of experiencing any complication, CAD and retinopathy in men compared with women were 1.57 (95% CI: 1.27–2.03), 2.27 (95% CI: 1.72–2.99) and 0.72 (95% CI: 0.52–0.98), respectively, after adjusting for demographic factors, anthropometric measures, metabolic parameters and the consumption of dyslipidaemia drugs and antihyperglycaemic agents.Conclusion: The prevalence of diabetes complications was significantly higher in men with diabetes, highlighting the need for better treatment adherence. CAD was associated with the male gender, whereas retinopathy was associated with the female gender. Men and women with diabetes should be monitored closely for CAD and retinopathy, respectively, regardless of their age, diabetes duration, anthropometric measures, laboratory findings and medications.
- Open Access
- 9 April 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 174, 116525
Co-administration of “L-Lysine, Vitamin C, and Zinc” increased the antioxidant activity, decreased insulin resistance, and improved lipid profile in streptozotocin-induced diabetic rats
- 9 April 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 174, 116525
Open AccessCo-administration of “L-Lysine, Vitamin C, and Zinc” increased the antioxidant activity, decreased insulin resistance, and improved lipid profile in streptozotocin-induced diabetic rats
- Open Access
- 25 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0293410
Decreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study
Background: The prevalence of dyslipidemia in patients with type 2 diabetes (T2D) has been reported to be relatively high. The current study aimed to investigate the trend of serum lipid levels and the prevalence of dyslipidemia in patients with T2D. Methods: Data were extracted from a cohort of patients with T2D who had regular follow-ups every year for three years. TG, TC, LDL-C, HDL-C, and non-HDL-C were analyzed. The atherogenic index of plasma (AIP) was calculated using log (TG/HDL-C). Results: A total of 747 patients with T2D were included in this study, consisting of 469 (62.8%) women and 278 (37.2%) men. There was a significant downward trend in mean TG, TC, LDL-C, non-HDL-C, and AIP levels. The trend of mean HDL-C levels showed no significant change. The prevalence of high TG, high TC, high LDL-C, and high non-HDL-C significantly decreased from the first to the last visit. There was no significant change in the trend of prevalence of low HDL-C. The prevalence of high AIP significantly decreased in women and showed no significant changes in men. Conclusions: A decreasing trend was observed in the mean levels and prevalence of TG, TC, LDL-C, non-HDL-C, and AIP. HDL-C did not change significantly. The success rate in achieving a complete normal lipid profile during follow-up years was not promising and continues to be challenging.
- 25 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0293410
Open AccessDecreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study
Background: The prevalence of dyslipidemia in patients with type 2 diabetes (T2D) has been reported to be relatively high. The current study aimed to investigate the trend of serum lipid levels and the prevalence of dyslipidemia in patients with T2D. Methods: Data were extracted from a cohort of patients with T2D who had regular follow-ups every year for three years. TG, TC, LDL-C, HDL-C, and non-HDL-C were analyzed. The atherogenic index of plasma (AIP) was calculated using log (TG/HDL-C). Results: A total of 747 patients with T2D were included in this study, consisting of 469 (62.8%) women and 278 (37.2%) men. There was a significant downward trend in mean TG, TC, LDL-C, non-HDL-C, and AIP levels. The trend of mean HDL-C levels showed no significant change. The prevalence of high TG, high TC, high LDL-C, and high non-HDL-C significantly decreased from the first to the last visit. There was no significant change in the trend of prevalence of low HDL-C. The prevalence of high AIP significantly decreased in women and showed no significant changes in men. Conclusions: A decreasing trend was observed in the mean levels and prevalence of TG, TC, LDL-C, non-HDL-C, and AIP. HDL-C did not change significantly. The success rate in achieving a complete normal lipid profile during follow-up years was not promising and continues to be challenging.